Project Number 5R01AG059640-04 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Biomarker Predictors of Memantine Sensitivity in patients with Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 9. Other Researcher and Organization Principal Investigator SWERDLOW, NEAL R Principal Investigator First Name NEAL R Principal Investigator Last Name SWERDLOW Awardee Organization UNIVERSITY OF CALIFORNIA SAN DIEGO Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-365: Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01) FY Overall Cost $394,896 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
